Literature DB >> 22453293

Non-invasive prenatal diagnosis for fetal sex determination: benefits and disadvantages from the service users' perspective.

Celine Lewis1, Melissa Hill, Heather Skirton, Lyn S Chitty.   

Abstract

Prenatal fetal sex determination is clinically indicated for women who are at risk of having a child with a serious genetic disorder affecting a particular sex. Ultrasound has been the traditional method used, but early fetal sex determination using non-invasive prenatal diagnosis (NIPD) can now be performed using cell-free fetal DNA in maternal plasma. The study aim was to assess the views and experiences of service users who had used NIPD for fetal sex determination. In this paper, we report on the perceived benefits and disadvantages. A qualitative approach using semi-structured interviews was used. A total of 44 participants (38 women and 6 partners of participating women) were recruited. Participants' views and experiences of NIPD were overwhelmingly positive. Concerning benefits over traditional methods, three themes emerged: (1) technical aspects of technology; (2) timing; and (3) enhanced decision-making. Practical advantages of NIPD included avoiding miscarriage, and there were a number of psychological advantages associated with timing such as perceived control, early re-engagement, normalization of pregnancy and peace of mind. Participants also valued NIPD as it enabled a stepwise approach to decision-making. A number of disadvantages were discussed including concerns about social sexing and increased bonding at a time in pregnancy when miscarriage risk is high. However, participants felt these were fairly minor in comparison with the advantages of NIPD. Until definitive genetic diagnosis using NIPD is available, NIPD for fetal sex determination is perceived as a good interim measure with a number of notable advantages over traditional methods.

Entities:  

Mesh:

Year:  2012        PMID: 22453293      PMCID: PMC3476712          DOI: 10.1038/ejhg.2012.50

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  36 in total

1.  Personal experiences of cystic fibrosis (CF) carrier couples prospectively identified in CF families.

Authors:  Lidewij Henneman; Loes Kooij; Katelijne Bouman; Leo P ten Kate
Journal:  Am J Med Genet       Date:  2002-07-15

2.  The sagittal sign. An early second trimester sonographic indicator of fetal gender.

Authors:  D S Emerson; R E Felker; D L Brown
Journal:  J Ultrasound Med       Date:  1989-06       Impact factor: 2.153

3.  Maternal tasks in pregnancy.

Authors:  R Rubin
Journal:  Matern Child Nurs J       Date:  1975

Review 4.  The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis.

Authors:  Caroline F Wright; Hilary Burton
Journal:  Hum Reprod Update       Date:  2008-10-22       Impact factor: 15.610

5.  Will the introduction of non-invasive prenatal diagnostic testing erode informed choices? An experimental study of health care professionals.

Authors:  Ananda van den Heuvel; Lyn Chitty; Elizabeth Dormandy; Ainsley Newson; Zuzana Deans; Sophie Attwood; Shelley Haynes; Theresa M Marteau
Journal:  Patient Educ Couns       Date:  2009-06-26

Review 6.  Chorion villus sampling versus amniocentesis for prenatal diagnosis.

Authors:  Z Alfirevic; C M Gosden; J P Neilson
Journal:  Cochrane Database Syst Rev       Date:  2000

7.  Longitudinal study of the carrier testing process for fragile X syndrome: perceptions and coping.

Authors:  A McConkie-Rosell; G A Spiridigliozzi; J A Sullivan; D V Dawson; A M Lachiewicz
Journal:  Am J Med Genet       Date:  2001-01-01

8.  The attitude of women toward current and future possibilities of diagnostic testing in maternal blood using fetal DNA.

Authors:  Loes Kooij; Tjeerd Tymstra; Paul van den Berg
Journal:  Prenat Diagn       Date:  2009-02       Impact factor: 3.050

9.  Impact of prenatal testing on maternal-fetal bonding: chorionic villus sampling versus amniocentesis.

Authors:  N Caccia; J M Johnson; G E Robinson; T Barna
Journal:  Am J Obstet Gynecol       Date:  1991-10       Impact factor: 8.661

10.  Favorable attitudes toward testing for chromosomal abnormalities via analysis of fetal cells in maternal blood.

Authors:  S T Zamerowski; M A Lumley; R A Arreola; K Dukes; L Sullivan
Journal:  Genet Med       Date:  2001 Jul-Aug       Impact factor: 8.822

View more
  24 in total

1.  "Don't Want No Risk and Don't Want No Problems": Public Understandings of the Risks and Benefits of Non-Invasive Prenatal Testing in the United States.

Authors:  Megan Allyse; Lauren Carter Sayres; Taylor Goodspeed; Marsha Michie; Mildred K Cho
Journal:  AJOB Empir Bioeth       Date:  2015

2.  Will the introduction of non-invasive prenatal testing for Down's syndrome undermine informed choice?

Authors:  Caroline Silcock; Lih-Mei Liao; Melissa Hill; Lyn S Chitty
Journal:  Health Expect       Date:  2014-02-20       Impact factor: 3.377

3.  Perspectives of Pregnant People and Clinicians on Noninvasive Prenatal Testing: A Systematic Review and Qualitative Meta-synthesis.

Authors:  Meredith Vanstone; Alexandra Cernat; Umair Majid; Forum Trivedi; Chanté De Freitas
Journal:  Ont Health Technol Assess Ser       Date:  2019-02-19

4.  Cell-free fetal DNA testing for fetal aneuploidy and beyond: clinical integration challenges in the US context.

Authors:  Megan Allyse; Lauren C Sayres; Jaime S King; Mary E Norton; Mildred K Cho
Journal:  Hum Reprod       Date:  2012-08-03       Impact factor: 6.918

5.  Non-invasive prenatal testing: UK genetic counselors' experiences and perspectives.

Authors:  Elizabeth Alexander; Susan Kelly; Lauren Kerzin-Storrar
Journal:  J Genet Couns       Date:  2014-10-15       Impact factor: 2.537

6.  Genome-Wide Noninvasive Prenatal Diagnosis of De Novo Mutations.

Authors:  Ravit Peretz-Machluf; Tom Rabinowitz; Noam Shomron
Journal:  Methods Mol Biol       Date:  2021

7.  Is preparation a good reason for prenatal genetic testing? Ethical and critical questions.

Authors:  Marsha Michie
Journal:  Birth Defects Res       Date:  2020-03-01       Impact factor: 2.344

8.  Non-invasive prenatal testing for single gene disorders: exploring the ethics.

Authors:  Zuzana Deans; Melissa Hill; Lyn S Chitty; Celine Lewis
Journal:  Eur J Hum Genet       Date:  2012-11-28       Impact factor: 4.246

9.  Non-invasive Prenatal Diagnosis for BRCA Mutations - a Qualitative Pilot Study of Health Professionals' Views.

Authors:  Jade Bennett; Lyn Chitty; Celine Lewis
Journal:  J Genet Couns       Date:  2015-07-16       Impact factor: 2.537

10.  Limited Clinical Utility of Non-invasive Prenatal Testing for Subchromosomal Abnormalities.

Authors:  Kitty K Lo; Evangelia Karampetsou; Christopher Boustred; Fiona McKay; Sarah Mason; Melissa Hill; Vincent Plagnol; Lyn S Chitty
Journal:  Am J Hum Genet       Date:  2015-12-17       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.